Novel Genetic Variant of a Class B G Protein-Coupled Receptor Reveals a Role for Adrenomedullin in Human Fertility

Autor Hay, Debbie L.
Vydáno v ACS Pharmacol Transl Sci (2018)

Structure–function relationships of the N-terminus of receptor activity-modifying proteins

Autor Qi, Tao, Hay, Debbie L
Vydáno 2010

Reply to comment on: A second trigeminal CGRP receptor: function and expression of the AMY1 receptor

Autor Walker, Christopher S., Hay, Debbie L.
Vydáno v Ann Clin Transl Neurol (2016)

Secretin family (Class B) G protein-coupled receptors – from molecular to clinical perspectives

Autor Poyner, David R, Hay, Debbie L
Vydáno 2012

Amylin structure–function relationships and receptor pharmacology: implications for amylin mimetic drug development

Autor Bower, Rebekah L, Hay, Debbie L
Vydáno v Br J Pharmacol (2016)

RAMPs (Receptor-Activity Modifying Proteins): New Insights and Roles

Autor Hay, Debbie L., Pioszak, Augen A.
Vydáno v Annu Rev Pharmacol Toxicol (2015)

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

Autor Pioszak, Augen A., Hay, Debbie L.
Vydáno v Adv Pharmacol (2020)

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYI...

Autor Lee, Sang-Min, Hay, Debbie L., Pioszak, Augen A.
Vydáno v J Biol Chem (2016)

Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYI...

Autor Lee, Sang-Min, Hay, Debbie L., Pioszak, Augen A.
Vydáno v J Biol Chem (2016)

Agonist bias and agonist‐dependent antagonism at corticotrophin releasing factor receptors

Autor Tasma, Zoe, Wills, Peter, Hay, Debbie L., Walker, Christopher S.
Vydáno v Pharmacol Res Perspect (2020)

Antagonism of CGRP Signaling by Rimegepant at Two Receptors

Autor Pan, Kylie S., Siow, Andrew, Hay, Debbie L., Walker, Christopher S.
Vydáno v Front Pharmacol (2020)

Characterization of the Structure of RAMP1 by Mutagenesis and Molecular Modeling

Autor Simms, John, Hay, Debbie L., Wheatley, Mark, Poyner, David R.
Vydáno 2006

The pharmacology of Adrenomedullin 2/Intermedin

Autor Hong, Yanguo, Hay, Debbie L, Quirion, Remi, Poyner, David R
Vydáno 2012

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Autor Hay, Debbie L, Garelja, Michael L, Poyner, David R, Walker, Christopher S
Vydáno v Br J Pharmacol (2017)

Differential activation of G-proteins by μ-opioid receptor agonists

Autor Saidak, Zuzana, Blake-Palmer, Katherine, Hay, Debbie L, Northup, John K, Glass, Michelle
Vydáno 2006

The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling

Autor Kuwasako, Kenji, Hay, Debbie L, Nagata, Sayaka, Hikosaka, Tomomi, Kitamura, Kazuo, Kato, Johji
Vydáno 2012

Analysis of Amylin Consensus Sequences Suggests that Human Amylin is Not Optimized to Minimize Amyloid Formation and Provides Clues to Factors that Modulate Amyloidogenicity

Autor Noh, Daeun, Bower, Rebekah L, Hay, Debbie L, Zhyvoloup, Alexander, Raleigh, Daniel P
Vydáno v ACS Chem Biol (2020)

Structure–activity relationships for α-calcitonin gene-related peptide

Autor Watkins, Harriet A, Rathbone, Dan L, Barwell, James, Hay, Debbie L, Poyner, David R
Vydáno 2013

CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured

Autor Walker, Christopher S, Raddant, Ann C, Woolley, Michael J, Russo, Andrew F, Hay, Debbie L
Vydáno v Cephalalgia (2017)

Probing the Mechanism of Receptor Activity–Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Pept...

Autor Booe, Jason M., Warner, Margaret L., Roehrkasse, Amanda M., Hay, Debbie L., Pioszak, Augen A.
Vydáno v Mol Pharmacol (2018)